Article

Wavefront-guided PRK after previous keratorefractive surgery safe, effective in study

Wavefront-guided PRK in eyes with high aberrations after keratorefractive surgery was highly predictable and safe, with the vast majority of patients within 0.50 D of the intended correction, said Edward Manche, MD, of Stanford University School of Medicine, Stanford, CA.

Wavefront-guided PRK in eyes with high aberrations after keratorefractive surgery was highly predictable and safe, with the vast majority of patients within 0.50 D of the intended correction, said Edward Manche, MD, of Stanford University School of Medicine, Stanford, CA.

The study included 25 eyes of 21 patients. Fourteen patients had undergone a previous LASIK, nine had had radial keratotomy, and two had had PRK. All patients were treated with the VISX S4 excimer laser and the VISX WaveScan aberrometer.

Dr. Manche reported that there was a significant transient hyperopic overshoot 1 month after the treatment, especially in the patients who had undergone a previous LASIK procedure. He reported that 61% of patients had 20/20 or better.

The predictability of the PRK was very good, with 83% of patients within 0.50 D of the intended correction. No complications developed. All eyes had completely re-epithelialized in 7 days and no haze developed.

The safety was excellent. At 6 months, 23% had a one line or greater increase in the best-corrected visual acuity. At this time point, the uncorrected visual acuity had improved to 20/16.

Patients reported resolution of ghosting of vision. The topography was markedly improved with better centration, and there was a significant decrease in total root mean square values and specifically coma.

"We obtained excellent uncorrected visual acuity and best spectacle-corrected visual acuity, with 23% of eyes having an increase of one or more lines of best-corrected vision at 6 months," Dr. Manche said. "The safety and predictability of the procedure were excellent. There was a significant delay in uncorrected and best spectacle-corrected visual recovery. There was a slight reduction in the total root-mean-square values and not change in trefoil or spherical aberration."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.